文献速递肿瘤 PET/CT

18F-FDG PET评估恶性胸膜间皮瘤:病灶总体积与病灶总糖酵解——体积的核心作用

18F-FDG PET Assessment of Malignant Pleural Mesothelioma: Total Lesion Volume and Total Lesion Glycolysis-The Central Role of Volume.
PubMed 文献 · J Nucl Med · 2020-04-13

本研究开发基于阈值的18F-FDG PET肿瘤体积测量程序,对19例恶性胸膜间皮瘤患者在化疗免疫治疗2周期(6周)前后测量TLV、TLG、SULtotal和SULaverage。结果显示TLG与TLV强相关,SULaverage波动范围窄(2.4-5.3),TLV是TLG的主要成分,SULtotal与TLV强相关(r=0.99,P<0.01)。

要点

  • 在19例恶性胸膜间皮瘤患者中,TLG与TLV强相关,TLV是TLG的主要成分。
  • SULaverage在2.4-5.3单位窄范围内波动,而TLV跨3个数量级。
  • SULtotal与TLV强相关(r=0.99,P<0.01),18F-FDG摄取与肿瘤体积成比例。

核心结论

  • TLG等于TLV乘以SULaverage,实质上是TLV乘以一个常数,因此在本队列中TLG也是肿瘤体积的度量。
  • SULaverage的恒定性源于18F-FDG摄取与肿瘤体积成比例,故在本研究中18F-FDG摄取也是体积的度量。

研究设计与样本

  • 开发了基于阈值的交互式数据语言程序,用于测量18F-FDG PET图像中的肿瘤体积。
  • 研究了19例恶性胸膜间皮瘤患者,在化疗免疫治疗2周期(6周)前后进行测量。
  • 测量指标包括TLV、TLG、SULtotal(肿瘤内SUL总和)和SULaverage。

主要发现

  • 基线TLV范围为11至2,610 cm3,TLG范围为32至8,552 cm3 g/mL,TLG与TLV强相关。
  • 肿瘤体积跨越3个数量级,而SULaverage保持在2.4-5.3单位的窄范围内。
  • TLV是TLG的主要成分,SULaverage是次要成分且基本恒定。
  • SULaverage的两个组分SULtotal和TLV平行变化且强相关(r=0.99,P<0.01)。
  • 无论肿瘤大小,SULtotal所测的18F-FDG摄取与TLV成比例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cancer survival is related to tumor volume. 18F-FDG PET measurement of tumor volume holds promise but is not yet a clinical tool. Measurements come in 2 forms: the first is total lesion volume (TLV) based on the number of voxels in the tumor, and the second is total lesion glycolysis (TLG), which is the TLV multiplied by the average SUL (i.e., SUV normalized for lean mass) of the tumor (SULaverage). In this study, we measured tumor volume in patients with malignant pleural mesothelioma (MPM). Methods: A threshold-based program in Interactive Data Language was developed to measure tumor volume in 18F-FDG PET images. Nineteen patients with MPM were studied before and after 2 cycles (6 wk) of chemoimmunotherapy. Measurements included TLV, TLG, the sum of the SULs in the tumor (SULtotal, a measure of total 18F-FDG uptake), and SULaverageResults: Baseline TLV ranged from 11 to 2,610 cm3 TLG ranged from 32 to 8,552 cm3 g/mL and correlated strongly with TLV. Although tumor volumes ranged over 3 orders of magnitude, SULaverage stayed within a narrow range of 2.4-5.3 units. Thus, TLV was the major component of TLG, whereas SULaverage was a minor component and was essentially constant. Further evaluation of SULaverage showed that in this cohort its 2 components, SULtotal and TLV, changed in parallel and were strongly correlated (r = 0.99, P < 0.01). Thus, whether the tumors were large or small, 18F-FDG uptake as measured by SULtotal was proportional to the TLV. Conclusion: TLG equals TLV multiplied by SULaverage, essentially TLV multiplied by a constant. Thus TLG, commonly considered a measure of metabolic activity in tumors, is also in this cohort a measure of tumor volume. The constancy of SULaverage is due to the fact that 18F-FDG uptake is proportional to tumor volume. Thus, in this study, 18F-FDG uptake was also a measure of volume.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Reynolds JC, Maass-Moreno R, Thomas A, et al. 18F-FDG PET Assessment of Malignant Pleural Mesothelioma: Total Lesion Volume and Total Lesion Glycolysis-The Central Role of Volume. J Nucl Med. 2020. PMID: 32284398. doi:10.2967/jnumed.119.238733

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。